1. Clinical and subclinical features of post-vaccination reactions in children under 5 years old treated at The National Children's Hospital from 2019 to 2021

Pham Ngoc Toan, Ton Thi Thuy, Le Ngoc Duy

Main Article Content

Abstract

Our research was conducted at the National Children's Hospital from January 2019 to December 2021, employing a cross-sectional descriptive research methodology involving 103 children under 5 years of age who had undergone vaccination. The study aimed to explore both clinical and subclinical features of vaccination reactions in children. The key findings are as follows: The most prevalent reaction, observed in 47.6% of the children, was a high fever (> 38.5°C). Secondly, crying was reported in 10.6% of cases, difficulty breathing in 8.7%, and pallor in 7.7%. Additionally, 6.8% of the children experienced symptoms such as feeding difficulties, while 5% encountered other reactions, including hives, pain at the injection site, seizures, vomiting, diarrhea, and edema. Additional signs, such as petechiae, cold skin, fatigue, and an elevated heart rate, were also documented. Vaccine type 5.1 demonstrated the highest incidence of post-vaccination reactions. 55.3% exhibited elevated C-reactive protein (CRP) levels, while the remaining 44.7% maintained normal CRP levels, with an average value of approximately 11.7 mg/L. The majority of reactions occurred in children under 6 months of age, predominantly after the administration of vaccine 5.1. In most cases, symptoms manifested early, with fever and feeding difficulties being the most common, and most children exhibited normal subclinical outcomes.

Article Details

References

1. Nguyen CT. Assessment of adverse events following immunization of Quinvaxem vaccine for infants under one year of age in Hanoi, 2013. VJPM. 2017; 27: 42-49.
2. McNeil MM, Weintraub ES, Duffy J, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016; 137(3): 868-878.
3. Clark S, Wei W, Rudders SA, et al. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol. 2014; 134(5): 1125-1130.
4. Gonzalez-Perez A, Aponte Z, Vidaurre CF, et al. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol. 2010; 125(5): 1098-1104.e1.
5. Singh AK, Wagner AL. Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience. Expert Rev Vaccines. 2018 Jun; 17(6): 555-562. doi: 10.1080/14760584.2018.1484285. Epub 2018 Jun 11.
6. Ngô Thị Thanh, Trần Minh Tiến, Trần Như Dân, Lê Hoàng Đăng, Phạm Quang Thái. Phản ứng nặng trong tiêm chủng mở rộng ở miền Bắc Việt Nam từ 2013 - 2017 và một số yếu tố liên quan. Tạp Chí Y học Dự phòng. 2018; 28(6)
7. Trần Văn Thiện, Trần Mạnh Tùng, Dương Thị Hồng, Trần Như Dương, Lê Hoàng Nam, Phạm Văn Khang, Nguyễn Thị Bích Liên, Phạm Quang Thái. Đặc điểm các trường hợp phản ứng nặng sau tiêm trong tiêm chủng mở rộng tại miền Bắc Việt Nam từ năm 2016 - 2020 và một số yếu tố liên quan tới tiên lượng. Tạp Chí Y học Dự phòng. 2021; 31(9): 30-38.
8. Đinh Thị Thu Phương, Lê Ngọc Duy, Trương Thị Mai Hồng. Nguyên nhân phản vệ và đặc điểm lâm sàng theo nguyên nhân ở trẻ em tại Bệnh viện Nhi Trung ương (2017-2021). Tạp Chí Y học Việt Nam. 2021; 507(1).